A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LVESVI / LV end-systolic volume index

[Related PubMed/MEDLINE]
Total Number of Papers: 47
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LVESVI  (>> Co-occurring Abbreviation)
Long Form:   LV end-systolic volume index
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial. CaMKIId, CMR, LV, LVEF, PCI, STEMI
2021 l -Arginine Can Enhance the Beneficial Effect of Losartan in Patients with Chronic Aortic Regurgitation and Isolated Systolic Hypertension. ARB, CAR, DBP, ISH, LVEDVI, LVMI, SBP
2020 Addition of Chinese herbal remedy, Tongguan Capsules, to the standard treatment in patients with myocardial infarction improve the ventricular reperfusion and remodeling: Proteomic analysis of possible signaling pathways. LV, MI, TGC
2020 Association of Echocardiographic Left Ventricular End-Systolic Volume and Volume-Derived Ejection Fraction With Outcome in Asymptomatic Chronic Aortic Regurgitation. AR, LV, LVESDi, Vol-LVEF
2020 Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies. AS, CMR, LV, LVEDVI, LVEF, LVMI, MOOSE, SMD, TAVR
2020 Changes of Left Ventricular Systolic Function in Patients Undergoing Coronary Artery Bypass Grafting. CABG, LV, LVEDVI, LVEF, WMSI
2020 Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial. HF, LVD, LVEDVI, LVEF, MI, STEMI
2020 Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial. LV, STICH
2020 Left ventricle and mitral valve reverse remodeling in response to cardiac resynchronization therapy in nonischemic cardiomyopathy. CRT, LV, MV, NICMP
10  2019 Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. HFrEF, IQR, LAVI, LV, LVEDVI, NT-proBNP
11  2019 Biventricular pacing during cardiac magnetic resonance imaging. CMR, LV, LVEDVI, LVEF, MD, NYHA
12  2019 Cardiac MRI measurements of pericardial adipose tissue volumes in patients on in-centre nocturnal hemodialysis. CHD, CMR, EAT, INHD, LV, LVEDVI, LVEF, LVMI, PAT
13  2019 Echocardiographic assessment of left ventricular systolic function in neonatal calves with naturally occurring sepsis or septic shock due to diarrhea. BP, LV, LVEDVI
14  2019 Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial. AA, AG, AMI, ARA, EPA, FADS2, GG, GG, O3FA
15  2019 Less invasive ventricular enhancement (LIVE) as potential therapy for ischaemic cardiomyopathy end-stage heart failure. EF, FU, HF, LIVE, LV, MR, SVR
16  2018 Timing of Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy. LV, LVEF, LVSVI, MRA, NIDCM
17  2017 Associations between Left Ventricular Cavity Size and Cardiac Function and Overload Determined by Natriuretic Peptide Levels and a Covariance Structure Analysis. BNP, LV, LVEDVI, SVI
18  2017 Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging. CMR, LV, LVEDVI
19  2016 Effects of beta-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction. AMI, EF, LV, LVDd, LVDs, LVEDVI, PCI
20  2016 Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study. HF, LV, MI, NYHA, VAS
21  2016 Prognostic value of exercise left ventricular end-systolic volume index in patients with asymptomatic aortic regurgitation: an exercise echocardiography study. AR, AVR, LV, MACE
22  2015 Association of serum leptin with future left ventricular structure and function: The Multi-Ethnic Study of Atherosclerosis (MESA). CMR, LV, LVEDVI, MESA
23  2015 Efficacy of mitral valve repair as an adjunct procedure to coronary artery bypass grafting in moderate ischemic mitral regurgitation: a meta-analysis of randomized trials. CABG, CI, IMR, LVEF, MR, MVR, RCTs, RR
24  2015 Prediction of Long-Term Survival in Patients with End-Stage Heart Failure Secondary to Ischemic Heart Disease: Surgical Correction and Volumetric Analysis. EF, ICM, IHD, MR, RVSP, TR
25  2015 Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial. EF, LV, MI, SD, SPECT
26  2014 Association between cardiothoracic ratio, left ventricular size and systolic function in patients undergoing computed tomography coronary angiography. CTR, DSCT-CA, LV, LVEDVI, LVEF
27  2014 Novel MRI-derived quantitative biomarker for cardiac function applied to classifying ischemic cardiomyopathy within a Bayesian rule learning framework. BRL, HD, IHD, LV, LVEF
28  2014 Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival. CABG, MR, RMA, SVR
29  2012 Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. CRT, HF
30  2011 Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy. CRT, LV, MR
31  2011 Restrictive mitral annuloplasty with or without surgical ventricular restoration in ischemic dilated cardiomyopathy with severe mitral regurgitation. cine-MDCT, LV, LVEDVI, RMA, SVR
32  2011 Role of left ventricular dyssynchrony in predicting remodeling after ST elevation myocardial infarction. AMI, DT, LV, LVEDVI, PPCI, STEMI, TDI
33  2010 Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. CAD, LV, NT-proBNP
34  2010 Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). AMI, CMR, IL-1, LV, VCU-ART
35  2010 Myocardial perfusion grade after late infarct artery recanalization is associated with global and regional left ventricular function at one year: analysis from the Total Occlusion Study of Canada-2. IRAs, LV, LVEDVI, LVEF, MI, MPG, PCI, WMI
36  2010 Predictors of preserved left ventricular systolic function after surgery for chronic organic mitral regurgitation: a prospective study. CMR, LV, LVEDV, LVEDVI, LVEF, MR
37  2009 Reference values for left ventricular volumes with real-time 3-dimensional echocardiography. 2DE, EF, LV, LVEDVI, RT3DE, SD
38  2008 Analysis of left ventricular changes after acute myocardial infarction using transthoracic real-time three-dimensional echocardiography. AMI, LV, LVEDVI, LVSVI
39  2007 B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation. AR, BNP, LV
40  2006 Correlation between beat-to-beat QT interval variability and impaired left ventricular function in patients with previous myocardial infarction. EF, LV, LVEDVI, MI, QTV, QTVI
41  2006 The impact of unrepaired versus repaired mitral regurgitation on functional status of patients with ischemic cardiomyopathy at one year after coronary artery bypass grafting. CABG, ICM, LV, LVEDVI, LVEF, MR, MV, PAP
42  2004 The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). ACEI, CARMEN, HF, LV
43  2002 Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. LV, LVEDVI, MI, NT-proBNP
44  2002 The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. EF, LV, LVEDVI, NYHA
45  2000 Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size. AMI, CVR, LV, PTCA, RS
46  1994 Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril. ACE, LV, LVEDVI, MI, VAs
47  1992 Effects of reperfusion on left ventricular ejection fraction and volume after acute myocardial infarction. AMI, LV, LVEDVI, LVEF